← Back to Patent Explorer
US5169984A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthesis and characterization of N-bromoacetyl-3,3'5-triiodo-L-thyronine using high speed countercurrent chromatography

Assignee: United States Department of Health and Human Services
•
Filing: 1990-09-10
•
Granted: 1992-12-08
•
Expires: 2010-09-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for synthesizing N-bromoacetyl-3,3',5-triiodo-L-thyronine which involves subjecting 3,3', 5-triiodo-L-thyronine to a one-step bromacetylation reaction wherein 3,3', 5-triiodo-L-thyronine and bromoacetyl bromide are refluxed together in a solution of ethyl acetate. After formation the N-bromoacetyl-3,3'-triiodo-L-thyronine is purified by fractionation utilizing high speed countercurrent chromatography. Labeled N-bromoacetyl-3,3'-5-triiodo-L-thryonine may be made by a one-step bromacetylation reaction by reducing either [125I]T3 or [14C]T3 with bromoacetyl bromide.

Inventors

  • 👤 Hans J. Cahnmann
  • 👤 Yoichiro Ito

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 12:50
CPC Classifications
C; C07; C07C; C07C233/00; C07C233/01; C07C233/45; C07C233/46; C07C233/47; C07C231/00; C07C231/02; C07C231/22; C07C231/24

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 39 words
A method for synthesizing N-bromoacetyl3,3',5-triiodo-L-thyronine which comprises subjecting 3,3',5-triiodo-L-thyronine to a one-step bromoacetylation reaction with bromoacetyl bromide wherein after synthesis, said N-bromoacetyl-3,3',5-triiodo-L-thyronine is subjected to high speed countercurrent chromatography fractionation to obtain a product which consists essentially of N-bromoacetyl-3,3',5-triiodo-L-thyronine.
Claim 2
Independent Claim 39 words
A method for synthesizing N-bromoacetyl3,3',5-triiodo-L-thyronine which comprises subjecting 3,3',5-triiodo-L-thyronine to a one-step bromoacetylation reaction with bromoacetyl bromide wherein after synthesis, said N-bromoacetyl-3,3',5-triiodo-L-thyronine is subjected to high speed countercurrent chromatography fractionation to obtain a product which consists essentially of N-bromoacetyl-3,3',5-triiodo-L-thyronine.
Claim 3
Dependent Claim 31 words
A method for synthesizing N-bromoacetyl-3,3',5-triiodo-L-thyronine according to claim 1, wherein said high speed countercurrent chromatography utilizes a solvent system comprising hexane/ethyl acetate/methanol/15 mM ammonium acetate having a pH of about 4.0.
Claim 4
Dependent Claim 25 words
A method for synthesizing N-bromoacetyl-3,3',5-triiodo-L-thyronine according to claim 2, wherein said hexane/ethyl acetate/methanol/15 mM ammonium acetate are present in a ratio of 1:1:1:1 by volume.
Claim 5
Dependent Claim 25 words
A method for synthesizing N-bromoacetyl-3,3',5-triiodo-L-thyronine according to claim 2, wherein said hexane/ethyl acetate/methanol/15 mM ammonium acetate are present in a ratio of 4:5:4:5 by volume.
Claim 6
Dependent Claim 31 words
A method for synthesizing N-bromoacetyl-3,3',5-triiodo-L-thyronine according to claim 2, wherein said high speed countercurrent chromatography is conducted at a temperature in the range of from about 10° to about 30° C.
Claim 7
Dependent Claim 27 words
A method for synthesizing labeled N-bromoacetyl-3,3',5-triiodo-L-thyronine according to claim 1, further comprising labeling said N-bromoacetyl-3,3',5-triiodo-L-thyronine by conducting said bromoacetylation reaction in the presence of a labeled 3,3',5-triiodo-L-thyronine.
Claim 8
Dependent Claim 31 words
A method for synthesizing labeled N-bromoacetyl3,3',5-triiodo-L-thyronine according to claim 6, wherein said 3,3',5-triiodo-L-thyronine is labelled with an element selected from the group consisting of 125 I, 14 C, and mixtures thereof.
Claim 9
Independent Claim 25 words
A method of purifying crude N-bromoacetyl-3,3',5-triiodo-L-thyronine which comprises subjecting crude N-bromoacetyl-3,3',5-triiodo-L-thyronine to high speed countercurrent chromatography to obtain a product which consists essentially of N-bromoacetyl-3,3',5-triiodo-L-thyronine.
Claim 10
Independent Claim 25 words
A method of purifying crude N-bromoacetyl-3,3',5-triiodo-L-thyronine which comprises subjecting crude N-bromoacetyl-3,3',5-triiodo-L-thyronine to high speed countercurrent chromatography to obtain a product which consists essentially of N-bromoacetyl-3,3',5-triiodo-L-thyronine.
Claim 11
Dependent Claim 32 words
A method of purifying crude N-bromoacetyl-3,3',5-triiodo-L-thyronine according to claim 8, wherein said high speed countercurrent chromatography utilizes a solvent system comprising hexane/ethyl acetate/methanol/15 mM ammonium acetate having a pH of about 4.0.
Claim 12
Dependent Claim 26 words
A method of purifying crude N-bromoacetyl-3,3',5-triiodo-L-thyronine according to claim 9, wherein said hexane/ethyl acetate/methanol/15 mM ammonium acetate are present in a ratio of 1:1:1:1 by volume.
Claim 13
Dependent Claim 26 words
A method of purifying crude N-bromoacetyl-3,3',5-triiodo-L-thyronine according to claim 9, wherein said hexane/ethyl acetate/methanol/15 mM ammonium acetate are present in a ratio of 4:5:4:5 by volume.
Claim 14
Dependent Claim 32 words
A method of purifying crude N-bromoacetyl-3,3',5-triiodo-L-thyronine according to claim 9, wherein said high speed countercurrent chromatography is conducted at a temperature in the range of from about 10° to about 30° C.

References Cited (Backward Citations)

US4430216A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-12-08 1996-06-08 1996-12-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-12-08 2000-06-08 2000-12-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-12-08 2004-06-08 2004-12-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag